Featured Grand Rapids Allergists

Learn more about the medical training and expertise of allergists in Grand Rapids Michigan. Select from the list of allergists below.

More Grand Rapids Allergists

Learn more about the medical training and expertise of allergists in Grand Rapids Michigan. Select from the list of allergists below.

Patient Education

Allergy Shots (Immunotherapy)

Allergy shots can provide long-lasting relief of allergy symptoms even after the shots have stopped. Allergy shots can control symptoms triggered by seasonal allergies (hay fever), indoor allergens (pet allergy, mold allergy) or insect stings (bee sting allergy). Speak to your allergist to find out if allergy shots (immunotherapy) is a treatment option for you. More...

Anaphylaxis - What Is It?

Anaphylaxis is a life-threatening allergic reaction that may be triggered by foods, stinging insects, latex or medications. See an allergist to determine if you are at risk of anaphylaxis and if you should have an epinephrine auto-injector for cases of medical emergency. More...

Asthma Treatment and Medications

Asthma treatment involves the use of "rescue" medications to treat asthma symptoms and "preventive" medications to keep asthma under control, as well as a plan to track and manage your asthma symptoms. See your allergist about asthma treatment options and to develop a personalized Asthma Action Plan. More...

Biologics for Eczema

A class of medications called "biologics" may be prescribed for the treatment of severe eczema. Biologics, such as dupilumab, are delivered by injection and may be used in combination with other eczema treatments. More...

Biologics for Severe Asthma

Those with severe asthma which is not well controlled with other treatments may be prescribed a class of medications called “biologics”. Biologics are unique in that they target a specific antibody, molecule, or cell involved in asthma. Because of this, they are known as “precision” or “personalized” therapy. Currently there are five approved biologics for asthma – omalizumab, mepolizumab, reslizumab, benralizumab, and dupilumab – with several others currently in development. More...